Timing of β-Blocker Reintroduction and the Occurrence of Postoperative Atrial Fibrillation after Cardiac Surgery: A Prospective Cohort Study
WHAT WE ALREADY KNOW ABOUT THIS TOPICβ-blockers are usually stopped in cardiac surgical patientsWhen best to reintroduce them remains unknown, and is a trade-off between hemodynamic risk and development of atrial fibrillation WHAT THIS ARTICLE TELLS US THAT IS NEWThere was little advantage to reintr...
Gespeichert in:
Veröffentlicht in: | Anesthesiology (Philadelphia) 2020-02, Vol.132 (2), p.267-279 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 279 |
---|---|
container_issue | 2 |
container_start_page | 267 |
container_title | Anesthesiology (Philadelphia) |
container_volume | 132 |
creator | Couffignal, Camille Amour, Julien Ait-Hamou, Nora Cholley, Bernard Fellahi, Jean-Luc Duval, Xavier Costa De Beauregard, Yolande Nataf, Patrick Dilly, Marie-Pierre Provenchère, Sophie Montravers, Philippe Mentré, France Longrois, Dan |
description | WHAT WE ALREADY KNOW ABOUT THIS TOPICβ-blockers are usually stopped in cardiac surgical patientsWhen best to reintroduce them remains unknown, and is a trade-off between hemodynamic risk and development of atrial fibrillation
WHAT THIS ARTICLE TELLS US THAT IS NEWThere was little advantage to reintroducing β-blockers within 48 hThe odds of atrial fibrillation were significantly reduced by restarting β-blockers between 72 and 96 h after surgery
BACKGROUND:For cardiac surgery patients under chronic β-blocker therapy, guidelines recommend their early postoperative reintroduction to decrease the incidence of postoperative atrial fibrillation. The authors hypothesized that the timing of β-blocker reintroduction affects their effectiveness on the incidence of postoperative atrial fibrillation.
METHODS:This multicenter prospective French cohort study included patients on β-blockers (more than 30 days before surgery) in sinus rhythm without a pacemaker. The primary outcome, time sequence of β-blocker reintroduction, was analyzed for 192 h after surgery. The secondary outcome, relationship between the occurrence of postoperative atrial fibrillation and timing of β-blocker reintroduction, was analyzed based on pre- and intraoperative predictors (full and selected sets) according to landmark times (patients in whom atrial fibrillation occurred before a given landmark time were not analyzed).
RESULTS:Of 663 patients, β-blockers were reintroduced for 532 (80%) but for only 261 (39%) patients in the first 48 h after surgery. Median duration before reintroduction was 49.5 h (95% CI, 48 to 51.5 h). Postoperative atrial fibrillation or death (N = 4) occurred in 290 (44%) patients. After performing a landmark analysis to take into account the timing of β-blocker reintroduction, the adjusted odds ratios (95% CI) for predictor full and selected (increased age, history of paroxysmal atrial fibrillation, and duration of aortic cross clamping) sets for the occurrence of postoperative atrial fibrillation wereadjusted odds ratio (full) = 0.87 (0.58 to 1.32; P = 0.517) and adjusted odds ratio (selected) = 0.84 (0.58 to 1.21; P = 0.338) at 48 h; adjusted odds ratio (full) = 0.64 (0.39 to 1.05; P = 0.076) and adjusted odds ratio (selected) = 0.58 (0.38 to 0.89; P = 0.013) at 72 h; adjusted odds ratio (full) = 0.58 (0.31 to 1.07; P = 0.079) and adjusted odds ratio (selected) = 0.53 (0.31 to 0.91; P = 0.021) at 96 h.
CONCLUSIONS:β-Blockers were reintroduced early (after less than 48 h) |
doi_str_mv | 10.1097/ALN.0000000000003064 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_inserm_02444336v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31850941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3024-32d6579504325f607ca43f0b4698a23ce5381d38a2512a225691c1b044bae0b23</originalsourceid><addsrcrecordid>eNqFkVtO3DAUhq2qqEyhO6gqL6ABX3PpWzoqpdIIUIFny3FOiIsnHjkOaBbRzXQhXVM9BBDqQ2vZOrb1f8c-50foPSVHlFTFcb06OyIvBie5eIUWVLIyo7SQr9Fid5txwtg-ejuOP9KxkLx8g_Y5LSWpBF2gn1d2bYcb7Dv8-1f22XlzCwF_BzvE4NvJROsHrIcWxx7wuTFTCDAY2Okv_Bj9BoKO9g5wHYPVDp_YJljn9Mx1MSVb6tBabfDlFG4gbD_hGl8EP27APIBL3_sQ8WWc2u0h2uu0G-HdYzxA1ydfrpan2er867dlvcpMqkZknLW5LCpJBGeyy0lhtOAdaURelZpxA6lK2vK0l5RpxmReUUMbIkSjgTSMH6CPc95eO7UJdq3DVnlt1Wm9UnYYIaxVekgIzvM7muRilpv07zFA98xQonZmqGSG-tuMhH2Ysc3UrKF9hp66nwTlLLj3LnVqvHXTPQTVg3ax_19u8Q_0QScFyxhhZDdJlhZl_A88FKY-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Timing of β-Blocker Reintroduction and the Occurrence of Postoperative Atrial Fibrillation after Cardiac Surgery: A Prospective Cohort Study</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Journals@Ovid Complete</source><creator>Couffignal, Camille ; Amour, Julien ; Ait-Hamou, Nora ; Cholley, Bernard ; Fellahi, Jean-Luc ; Duval, Xavier ; Costa De Beauregard, Yolande ; Nataf, Patrick ; Dilly, Marie-Pierre ; Provenchère, Sophie ; Montravers, Philippe ; Mentré, France ; Longrois, Dan</creator><creatorcontrib>Couffignal, Camille ; Amour, Julien ; Ait-Hamou, Nora ; Cholley, Bernard ; Fellahi, Jean-Luc ; Duval, Xavier ; Costa De Beauregard, Yolande ; Nataf, Patrick ; Dilly, Marie-Pierre ; Provenchère, Sophie ; Montravers, Philippe ; Mentré, France ; Longrois, Dan</creatorcontrib><description>WHAT WE ALREADY KNOW ABOUT THIS TOPICβ-blockers are usually stopped in cardiac surgical patientsWhen best to reintroduce them remains unknown, and is a trade-off between hemodynamic risk and development of atrial fibrillation
WHAT THIS ARTICLE TELLS US THAT IS NEWThere was little advantage to reintroducing β-blockers within 48 hThe odds of atrial fibrillation were significantly reduced by restarting β-blockers between 72 and 96 h after surgery
BACKGROUND:For cardiac surgery patients under chronic β-blocker therapy, guidelines recommend their early postoperative reintroduction to decrease the incidence of postoperative atrial fibrillation. The authors hypothesized that the timing of β-blocker reintroduction affects their effectiveness on the incidence of postoperative atrial fibrillation.
METHODS:This multicenter prospective French cohort study included patients on β-blockers (more than 30 days before surgery) in sinus rhythm without a pacemaker. The primary outcome, time sequence of β-blocker reintroduction, was analyzed for 192 h after surgery. The secondary outcome, relationship between the occurrence of postoperative atrial fibrillation and timing of β-blocker reintroduction, was analyzed based on pre- and intraoperative predictors (full and selected sets) according to landmark times (patients in whom atrial fibrillation occurred before a given landmark time were not analyzed).
RESULTS:Of 663 patients, β-blockers were reintroduced for 532 (80%) but for only 261 (39%) patients in the first 48 h after surgery. Median duration before reintroduction was 49.5 h (95% CI, 48 to 51.5 h). Postoperative atrial fibrillation or death (N = 4) occurred in 290 (44%) patients. After performing a landmark analysis to take into account the timing of β-blocker reintroduction, the adjusted odds ratios (95% CI) for predictor full and selected (increased age, history of paroxysmal atrial fibrillation, and duration of aortic cross clamping) sets for the occurrence of postoperative atrial fibrillation wereadjusted odds ratio (full) = 0.87 (0.58 to 1.32; P = 0.517) and adjusted odds ratio (selected) = 0.84 (0.58 to 1.21; P = 0.338) at 48 h; adjusted odds ratio (full) = 0.64 (0.39 to 1.05; P = 0.076) and adjusted odds ratio (selected) = 0.58 (0.38 to 0.89; P = 0.013) at 72 h; adjusted odds ratio (full) = 0.58 (0.31 to 1.07; P = 0.079) and adjusted odds ratio (selected) = 0.53 (0.31 to 0.91; P = 0.021) at 96 h.
CONCLUSIONS:β-Blockers were reintroduced early (after less than 48 h) in fewer than half of the cardiac surgery patients. Reintroduction decreased postoperative atrial fibrillation occurrence only at later time points and only in the predictor selected set model. These results are an incentive to optimize (timing, doses, or titration) β-blocker reintroduction after cardiac surgery.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/ALN.0000000000003064</identifier><identifier>PMID: 31850941</identifier><language>eng</language><publisher>United States: the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc</publisher><subject>Human health and pathology ; Life Sciences ; Pharmaceutical sciences ; Psychiatrics and mental health</subject><ispartof>Anesthesiology (Philadelphia), 2020-02, Vol.132 (2), p.267-279</ispartof><rights>the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc. All Rights Reserved.</rights><rights>Copyright © by 2019, the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc. All Rights Reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3024-32d6579504325f607ca43f0b4698a23ce5381d38a2512a225691c1b044bae0b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31850941$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-02444336$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Couffignal, Camille</creatorcontrib><creatorcontrib>Amour, Julien</creatorcontrib><creatorcontrib>Ait-Hamou, Nora</creatorcontrib><creatorcontrib>Cholley, Bernard</creatorcontrib><creatorcontrib>Fellahi, Jean-Luc</creatorcontrib><creatorcontrib>Duval, Xavier</creatorcontrib><creatorcontrib>Costa De Beauregard, Yolande</creatorcontrib><creatorcontrib>Nataf, Patrick</creatorcontrib><creatorcontrib>Dilly, Marie-Pierre</creatorcontrib><creatorcontrib>Provenchère, Sophie</creatorcontrib><creatorcontrib>Montravers, Philippe</creatorcontrib><creatorcontrib>Mentré, France</creatorcontrib><creatorcontrib>Longrois, Dan</creatorcontrib><title>Timing of β-Blocker Reintroduction and the Occurrence of Postoperative Atrial Fibrillation after Cardiac Surgery: A Prospective Cohort Study</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>WHAT WE ALREADY KNOW ABOUT THIS TOPICβ-blockers are usually stopped in cardiac surgical patientsWhen best to reintroduce them remains unknown, and is a trade-off between hemodynamic risk and development of atrial fibrillation
WHAT THIS ARTICLE TELLS US THAT IS NEWThere was little advantage to reintroducing β-blockers within 48 hThe odds of atrial fibrillation were significantly reduced by restarting β-blockers between 72 and 96 h after surgery
BACKGROUND:For cardiac surgery patients under chronic β-blocker therapy, guidelines recommend their early postoperative reintroduction to decrease the incidence of postoperative atrial fibrillation. The authors hypothesized that the timing of β-blocker reintroduction affects their effectiveness on the incidence of postoperative atrial fibrillation.
METHODS:This multicenter prospective French cohort study included patients on β-blockers (more than 30 days before surgery) in sinus rhythm without a pacemaker. The primary outcome, time sequence of β-blocker reintroduction, was analyzed for 192 h after surgery. The secondary outcome, relationship between the occurrence of postoperative atrial fibrillation and timing of β-blocker reintroduction, was analyzed based on pre- and intraoperative predictors (full and selected sets) according to landmark times (patients in whom atrial fibrillation occurred before a given landmark time were not analyzed).
RESULTS:Of 663 patients, β-blockers were reintroduced for 532 (80%) but for only 261 (39%) patients in the first 48 h after surgery. Median duration before reintroduction was 49.5 h (95% CI, 48 to 51.5 h). Postoperative atrial fibrillation or death (N = 4) occurred in 290 (44%) patients. After performing a landmark analysis to take into account the timing of β-blocker reintroduction, the adjusted odds ratios (95% CI) for predictor full and selected (increased age, history of paroxysmal atrial fibrillation, and duration of aortic cross clamping) sets for the occurrence of postoperative atrial fibrillation wereadjusted odds ratio (full) = 0.87 (0.58 to 1.32; P = 0.517) and adjusted odds ratio (selected) = 0.84 (0.58 to 1.21; P = 0.338) at 48 h; adjusted odds ratio (full) = 0.64 (0.39 to 1.05; P = 0.076) and adjusted odds ratio (selected) = 0.58 (0.38 to 0.89; P = 0.013) at 72 h; adjusted odds ratio (full) = 0.58 (0.31 to 1.07; P = 0.079) and adjusted odds ratio (selected) = 0.53 (0.31 to 0.91; P = 0.021) at 96 h.
CONCLUSIONS:β-Blockers were reintroduced early (after less than 48 h) in fewer than half of the cardiac surgery patients. Reintroduction decreased postoperative atrial fibrillation occurrence only at later time points and only in the predictor selected set model. These results are an incentive to optimize (timing, doses, or titration) β-blocker reintroduction after cardiac surgery.</description><subject>Human health and pathology</subject><subject>Life Sciences</subject><subject>Pharmaceutical sciences</subject><subject>Psychiatrics and mental health</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkVtO3DAUhq2qqEyhO6gqL6ABX3PpWzoqpdIIUIFny3FOiIsnHjkOaBbRzXQhXVM9BBDqQ2vZOrb1f8c-50foPSVHlFTFcb06OyIvBie5eIUWVLIyo7SQr9Fid5txwtg-ejuOP9KxkLx8g_Y5LSWpBF2gn1d2bYcb7Dv8-1f22XlzCwF_BzvE4NvJROsHrIcWxx7wuTFTCDAY2Okv_Bj9BoKO9g5wHYPVDp_YJljn9Mx1MSVb6tBabfDlFG4gbD_hGl8EP27APIBL3_sQ8WWc2u0h2uu0G-HdYzxA1ydfrpan2er867dlvcpMqkZknLW5LCpJBGeyy0lhtOAdaURelZpxA6lK2vK0l5RpxmReUUMbIkSjgTSMH6CPc95eO7UJdq3DVnlt1Wm9UnYYIaxVekgIzvM7muRilpv07zFA98xQonZmqGSG-tuMhH2Ysc3UrKF9hp66nwTlLLj3LnVqvHXTPQTVg3ax_19u8Q_0QScFyxhhZDdJlhZl_A88FKY-</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Couffignal, Camille</creator><creator>Amour, Julien</creator><creator>Ait-Hamou, Nora</creator><creator>Cholley, Bernard</creator><creator>Fellahi, Jean-Luc</creator><creator>Duval, Xavier</creator><creator>Costa De Beauregard, Yolande</creator><creator>Nataf, Patrick</creator><creator>Dilly, Marie-Pierre</creator><creator>Provenchère, Sophie</creator><creator>Montravers, Philippe</creator><creator>Mentré, France</creator><creator>Longrois, Dan</creator><general>the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc</general><general>Copyright by , the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc</general><general>Lippincott, Williams & Wilkins</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope></search><sort><creationdate>20200201</creationdate><title>Timing of β-Blocker Reintroduction and the Occurrence of Postoperative Atrial Fibrillation after Cardiac Surgery: A Prospective Cohort Study</title><author>Couffignal, Camille ; Amour, Julien ; Ait-Hamou, Nora ; Cholley, Bernard ; Fellahi, Jean-Luc ; Duval, Xavier ; Costa De Beauregard, Yolande ; Nataf, Patrick ; Dilly, Marie-Pierre ; Provenchère, Sophie ; Montravers, Philippe ; Mentré, France ; Longrois, Dan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3024-32d6579504325f607ca43f0b4698a23ce5381d38a2512a225691c1b044bae0b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Human health and pathology</topic><topic>Life Sciences</topic><topic>Pharmaceutical sciences</topic><topic>Psychiatrics and mental health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Couffignal, Camille</creatorcontrib><creatorcontrib>Amour, Julien</creatorcontrib><creatorcontrib>Ait-Hamou, Nora</creatorcontrib><creatorcontrib>Cholley, Bernard</creatorcontrib><creatorcontrib>Fellahi, Jean-Luc</creatorcontrib><creatorcontrib>Duval, Xavier</creatorcontrib><creatorcontrib>Costa De Beauregard, Yolande</creatorcontrib><creatorcontrib>Nataf, Patrick</creatorcontrib><creatorcontrib>Dilly, Marie-Pierre</creatorcontrib><creatorcontrib>Provenchère, Sophie</creatorcontrib><creatorcontrib>Montravers, Philippe</creatorcontrib><creatorcontrib>Mentré, France</creatorcontrib><creatorcontrib>Longrois, Dan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Couffignal, Camille</au><au>Amour, Julien</au><au>Ait-Hamou, Nora</au><au>Cholley, Bernard</au><au>Fellahi, Jean-Luc</au><au>Duval, Xavier</au><au>Costa De Beauregard, Yolande</au><au>Nataf, Patrick</au><au>Dilly, Marie-Pierre</au><au>Provenchère, Sophie</au><au>Montravers, Philippe</au><au>Mentré, France</au><au>Longrois, Dan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Timing of β-Blocker Reintroduction and the Occurrence of Postoperative Atrial Fibrillation after Cardiac Surgery: A Prospective Cohort Study</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>132</volume><issue>2</issue><spage>267</spage><epage>279</epage><pages>267-279</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><abstract>WHAT WE ALREADY KNOW ABOUT THIS TOPICβ-blockers are usually stopped in cardiac surgical patientsWhen best to reintroduce them remains unknown, and is a trade-off between hemodynamic risk and development of atrial fibrillation
WHAT THIS ARTICLE TELLS US THAT IS NEWThere was little advantage to reintroducing β-blockers within 48 hThe odds of atrial fibrillation were significantly reduced by restarting β-blockers between 72 and 96 h after surgery
BACKGROUND:For cardiac surgery patients under chronic β-blocker therapy, guidelines recommend their early postoperative reintroduction to decrease the incidence of postoperative atrial fibrillation. The authors hypothesized that the timing of β-blocker reintroduction affects their effectiveness on the incidence of postoperative atrial fibrillation.
METHODS:This multicenter prospective French cohort study included patients on β-blockers (more than 30 days before surgery) in sinus rhythm without a pacemaker. The primary outcome, time sequence of β-blocker reintroduction, was analyzed for 192 h after surgery. The secondary outcome, relationship between the occurrence of postoperative atrial fibrillation and timing of β-blocker reintroduction, was analyzed based on pre- and intraoperative predictors (full and selected sets) according to landmark times (patients in whom atrial fibrillation occurred before a given landmark time were not analyzed).
RESULTS:Of 663 patients, β-blockers were reintroduced for 532 (80%) but for only 261 (39%) patients in the first 48 h after surgery. Median duration before reintroduction was 49.5 h (95% CI, 48 to 51.5 h). Postoperative atrial fibrillation or death (N = 4) occurred in 290 (44%) patients. After performing a landmark analysis to take into account the timing of β-blocker reintroduction, the adjusted odds ratios (95% CI) for predictor full and selected (increased age, history of paroxysmal atrial fibrillation, and duration of aortic cross clamping) sets for the occurrence of postoperative atrial fibrillation wereadjusted odds ratio (full) = 0.87 (0.58 to 1.32; P = 0.517) and adjusted odds ratio (selected) = 0.84 (0.58 to 1.21; P = 0.338) at 48 h; adjusted odds ratio (full) = 0.64 (0.39 to 1.05; P = 0.076) and adjusted odds ratio (selected) = 0.58 (0.38 to 0.89; P = 0.013) at 72 h; adjusted odds ratio (full) = 0.58 (0.31 to 1.07; P = 0.079) and adjusted odds ratio (selected) = 0.53 (0.31 to 0.91; P = 0.021) at 96 h.
CONCLUSIONS:β-Blockers were reintroduced early (after less than 48 h) in fewer than half of the cardiac surgery patients. Reintroduction decreased postoperative atrial fibrillation occurrence only at later time points and only in the predictor selected set model. These results are an incentive to optimize (timing, doses, or titration) β-blocker reintroduction after cardiac surgery.</abstract><cop>United States</cop><pub>the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc</pub><pmid>31850941</pmid><doi>10.1097/ALN.0000000000003064</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-3022 |
ispartof | Anesthesiology (Philadelphia), 2020-02, Vol.132 (2), p.267-279 |
issn | 0003-3022 1528-1175 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_inserm_02444336v1 |
source | EZB-FREE-00999 freely available EZB journals; Journals@Ovid Complete |
subjects | Human health and pathology Life Sciences Pharmaceutical sciences Psychiatrics and mental health |
title | Timing of β-Blocker Reintroduction and the Occurrence of Postoperative Atrial Fibrillation after Cardiac Surgery: A Prospective Cohort Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T05%3A46%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Timing%20of%20%CE%B2-Blocker%20Reintroduction%20and%20the%20Occurrence%20of%20Postoperative%20Atrial%20Fibrillation%20after%20Cardiac%20Surgery:%20A%20Prospective%20Cohort%20Study&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=Couffignal,%20Camille&rft.date=2020-02-01&rft.volume=132&rft.issue=2&rft.spage=267&rft.epage=279&rft.pages=267-279&rft.issn=0003-3022&rft.eissn=1528-1175&rft_id=info:doi/10.1097/ALN.0000000000003064&rft_dat=%3Cpubmed_hal_p%3E31850941%3C/pubmed_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31850941&rfr_iscdi=true |